ARID1A and cancer: The expressional loss of ARID1A has been shown to trigger the initiation and progression of carcinogenesis in numerous types of cancers, including ovarian, breast, endometrial and cervical, breast, gastric, and colorectal cancers through several mechanisms that have not been fully elucidated [26].